|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/202 | |
| A61K 31/232 | |||
| A61P 7/12 | |||
| A61P 9/00 | |||
| A61P 9/10 | |||
| G01N 30/88 | |||
| G01N 33/50 | |||
| G01N 33/53 |
| (11) | Patento numeris | 2851069 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 13790182.3 |
| Europos patento paraiškos padavimo data | 2013-05-14 | |
| (97) | Europos patento paraiškos paskelbimo data | 2015-03-25 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2019-08-28 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/JP2013/063419 |
| Data | 2013-05-14 |
| (87) | Numeris | WO 2013/172344 |
| Data | 2013-11-21 |
| (30) | Numeris | Data | Šalis |
| 2012111900 | 2012-05-15 | JP |
| (72) |
KIYOHARA Yutaka, JP
NINOMIYA Toshiharu, JP
YANO Takashi, JP
|
| (73) |
Kyushu University, National University Corporation,
10-1, Hakozaki 6-chome Higashi-ku, Fukuoka-shi, Fukuoka 812-8581,
JP
Mochida Pharmaceutical Co., Ltd., 7 Yotsuya 1-chome Shinjuku-ku, Tokyo 160-8515, JP |
| (54) | CARDIOVASCULAR DISEASE PRIMARY PREVENTION AGENT FOR PATIENTS HAVING HIGH BLOOD LEVELS OF HIGH-SENSITIVITY C-REACTIVE PROTEIN |
| CARDIOVASCULAR DISEASE PRIMARY PREVENTION AGENT FOR PATIENTS HAVING HIGH BLOOD LEVELS OF HIGH-SENSITIVITY C-REACTIVE PROTEIN |